Abbott Laboratories banner

Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 88.18 USD -1.64% Market Closed
Market Cap: $153.6B

Wall St Price Targets

ABT Price Targets Summary
Abbott Laboratories

Wall Street analysts forecast ABT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABT is 120.77 USD with a low forecast of 92.92 USD and a high forecast of 142.8 USD.

Lowest Forecast
Price Target
92.92 USD
5% Upside
Average Forecast
Price Target
120.77 USD
37% Upside
Highest Forecast
Price Target
142.8 USD
62% Upside
Abbott Laboratories Competitors:
Price Targets
GWH
ESS Tech Inc
147% Upside

Revenue
Forecast

7% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 10%.

Gross Profit
Forecast

7% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 11%.

Operating Income
Forecast

15% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
15% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 20%.

Pre-Tax Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.

Net Income
Forecast

1% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss
1% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 22%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ABT's stock price target?
Price Target
120.77 USD

According to Wall Street analysts, the average 1-year price target for ABT is 120.77 USD with a low forecast of 92.92 USD and a high forecast of 142.8 USD.

What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 10%.

What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 20%.

What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
19%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.

What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
22%

Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett